AU9114598A - Method of monitoring blood low molecular weight heparin and heparin - Google Patents

Method of monitoring blood low molecular weight heparin and heparin

Info

Publication number
AU9114598A
AU9114598A AU91145/98A AU9114598A AU9114598A AU 9114598 A AU9114598 A AU 9114598A AU 91145/98 A AU91145/98 A AU 91145/98A AU 9114598 A AU9114598 A AU 9114598A AU 9114598 A AU9114598 A AU 9114598A
Authority
AU
Australia
Prior art keywords
heparin
molecular weight
low molecular
monitoring blood
blood low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91145/98A
Inventor
Haifeng Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Original Assignee
University of North Carolina at Chapel Hill
University of North Carolina System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, University of North Carolina System filed Critical University of North Carolina at Chapel Hill
Publication of AU9114598A publication Critical patent/AU9114598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7454—Tissue factor (tissue thromboplastin, Factor III)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
AU91145/98A 1997-08-26 1998-08-25 Method of monitoring blood low molecular weight heparin and heparin Abandoned AU9114598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92015197A 1997-08-26 1997-08-26
US08920151 1997-08-26
PCT/US1998/017434 WO1999010746A2 (en) 1997-08-26 1998-08-25 Method of monitoring blood low molecular weight heparin and heparin

Publications (1)

Publication Number Publication Date
AU9114598A true AU9114598A (en) 1999-03-16

Family

ID=25443255

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91145/98A Abandoned AU9114598A (en) 1997-08-26 1998-08-25 Method of monitoring blood low molecular weight heparin and heparin

Country Status (2)

Country Link
AU (1) AU9114598A (en)
WO (1) WO1999010746A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
US7358337B2 (en) 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134419A (en) * 1981-02-12 1982-08-19 Eisai Co Ltd Stable anticoagulant of blood
FR2587707B1 (en) * 1985-09-23 1988-01-08 Compiegne Universite Technolog GLYCOPEPTIDE AND ANY COMPOSITION CONTAINING IT, THEIR PREPARATION PROCESS AND THEIR ANTICOAGULANT APPLICATIONS
FR2675806B1 (en) * 1991-04-23 1994-06-10 Rhone Poulenc Rorer Sa SULPHATE POLYSACCHARIDES, METHOD OF PREPARATION, PHARMACEUTICAL COMPOSITION AND USE.
JP3416778B2 (en) * 1991-10-04 2003-06-16 デイド、ベーリング、インコーポレイテッド Production of prothrombin time reagent from recombinant human tissue factor and purified natural and synthetic phospholipids

Also Published As

Publication number Publication date
WO1999010746A3 (en) 1999-05-20
WO1999010746A2 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
AU4078999A (en) Monitoring catheter and method of using same
EP0758247A4 (en) O-desulfated heparin derivatives, methods of making and uses thereof
PL320692A1 (en) Novel anticoagulant, method of obtaining same and application thereof
AU3397900A (en) System and method for collecting platelets and other blood components
AU1858997A (en) Systems and methods for on-line finishing of cellular blood products like platelets harvested for therapeutic purposes
AU7293298A (en) Glucose detector and method
AU7250098A (en) Anastomosis system and method of use
AU3144897A (en) Exerciser and physical performance monitoring system
AU4462996A (en) Personal monitoring system and method
AU2071097A (en) Cannula and method of manufacture and use
AU5925499A (en) Pictorial-display electrocardiographic interpretation system and method
AU6169998A (en) Biocompatible polymers and methods for their use
AU4255497A (en) System and method for improving vascular blood flow
AU2390000A (en) Rheological treatment methods and related apheresis systems
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU4978097A (en) Catalyst and method of preparation
AU7385396A (en) Continuous monitoring of diabetes-related blood constituents
AU5326299A (en) Inflatable cannula and method of using same
AU3971797A (en) Blood aspirator
AU4250596A (en) Low molecular weight bicyclic thrombin inhibitors
AU6046998A (en) Method of measuring physiological function
AU2389600A (en) Reservoir-and-filter system and method of use
AU7753898A (en) Modified low molecular weight heparin that inhibits clot associated coagulation factors
AU5906898A (en) Responsive polymer networks and methods of their use
EP0898977A3 (en) Blood separation device and method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase